NOD:AG6-222:ileal:treatment_end:ABX017:ABX:0.56:0:6.64E+05:21:male

NOD:AG6-222:ileal:treatment_end:ABX018:ABX:0.61:0:4.98E+05:21:male

NOD:AG6-222:ileal:treatment_end:ABX022:ABX:2.22:0:1.34E+06:21:female

NOD:AG6-222:ileal:treatment_end:ABX024:ABX:12.40:0:6.79E+07:21:female

NOD:AG6-222:ileal:treatment_end:ABX027:placebo:37.70:0:1.01E+10:21:male

NOD:AG6-222:ileal:treatment_end:ABX028:placebo:16.50:0:2.04E+08:21:male

NOD:AG6-222:ileal:treatment_end:ABX029:placebo:8.36:0:3.29E+06:21:female

NOD:AG6-222:ileal:treatment_end:ABX031:placebo:17.40:0:1.56E+08:21:female

